Myeloma Minute: It's Myeloma Action Month - Take Action Now
|
| EMPOWERMENT | Myeloma Action Month
Join the Movement This Myeloma Action Month: Be a Myeloma WarriorToday, March 1st, we kick off Myeloma Action Month (MAM) campaign. This year’s campaign focuses on Myeloma Warriors - individuals like YOU who are surviving with the disease, supporting loved ones, or helping to find the cure. Join the movement by changing your Facebook, Instagram, Twitter profile pics to one of these Myeloma Warrior images. When you post messages on social media about MAM, use the hashtag #myelomawarrior and your messages will be streamed to our “Wall of Warriors.” We know that not everyone identifies with being a warrior. Myeloma patients, their friends and families, and health professionals, meet the challenge of this disease in thousands of different ways that are best for them. We honor your individuality and applaud your creativity! We welcome you to share your story today.
|
|
|
| ACTION | Fundraiser
|
| EDUCATION | Event
|
10 to Win the Fight |
Join Our Workshop in Denver |
|
The Southeastern Virginia (SEVA) Myeloma Networking Group has organized an IMF Fundraiser as part of Myeloma Action Month. The members of the SEVA Networking Group ask you to share this request with your family, friends, and neighbors to join the “Ten to Win” challenge. If 10 people donate just $10 and challenge their family and friends to do the same, there’s no limit to how much can be raised! Please join this challenge to help the IMF fund research for a cure. |
The IMF will host a Regional Community Workshop in Denver on Saturday, March 10, 2018. Registration is FREE, but seating is limited. Here’s your chance to learn from and meet one-on-one with myeloma experts Dr. Jeffrey Matous (Colorado Blood Cancer Institute, Denver, CO) and Dr. Craig Cole (University of Michigan, Ann Arbor, MI). |
|
|
|
|
| INNOVATION | Latest Research
At the One-Year Mark, the One-of-a-Kind iStopMM Project Is Already Revealing New InsightsCan early intervention and treatment prevent myeloma? The largest-ever myeloma project, sponsored by the IMF’s Black Swan Research Initiative®, is determined to find out. Based in Iceland, iStopMM® is screening nearly 80,000 people over age 40 for the earliest possible marker in the development of myeloma. On the project’s first-year anniversary, we take you behind the scenes in Reykjavik with the iStopMM team. The progress they’ve made so far is remarkable. We hope you agree.
|
|
|
| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series
|
|
CLINICAL TRIALS |
EVENTS |
|
New selinexor STORM Trial: Learn How to Participate New ARROW Clinical Trials: Learn How to Participate New ixazomib Clinical Trials: Learn How to Participate Join the conversation about myeloma on the Smart Patients Message Board |
March 10, 2018 March 10, 2018 March 16-17, 2018 April 8, 2018 April 21, 2018 April 28, 2018
|
Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology
and individuals like you who supported the IMF this year